Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Innospec Inc.NASDAQ: IOSP
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income grows, but more slowly than its trailing trend
Q2 FY2026 net income of $31.6M rose 34.5% year over year, behind the +533.7% change in trailing-twelve-month net income. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- Net income amounted to 6.6% of revenue in FY2025, up 4.6 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $125.92M (+8.0%) for the fiscal year ending Dec 2026, a slowdown from the +227.5% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $31.6M+3.9% QoQ
- Last fiscal yearDec 2025
- $116.6M+227.5% YoY
- LTMJun 2026
- $122.3M+533.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +34.5% | +141.7% | +107.2 pp |
| 1 year | +227.5% | +8.0% | -219.5 pp |
| 3-year CAGR | -4.3% | +13.0% | +17.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 116.6M USD
- Year-over-year change
- +227.5%
- 4-year CAGR
- +5.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 116.6M | +227.5% |
| FY2024 | 2024-12-31 | 35.6M | -74.4% |
| FY2023 | 2023-12-31 | 139.1M | +4.6% |
| FY2022 | 2022-12-31 | 133M | +42.9% |
| FY2021 | 2021-12-31 | 93.1M | — |
Net Income vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 net income of $122.3M is the 7th largest of the 10 companies compared; the peer median is $97.28M.
- Its year-over-year change of +533.7% is the 3rd highest of 10, against a peer median of +3.2%.
- Net income amounts to 6.6% of revenue for IOSP, versus a peer median of 6.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $683M | -18.4% | — | 37.1% | |
| LTM Jun 2026 | $442M | -47.1% | -15.9% | 5.0% | |
| LTM Jun 2026 | $433.37M | -9.8% | +14.4% | 15.8% | |
| LTM Jun 2026 | $217M | -51.5% | +15.7% | 6.0% | |
| LTM Aug 2026 | $197.76M | +71.8% | -5.6% | 5.6% | |
| LTM Sep 2026 | $176.9M | +375.5% | -41.6% | 3.4% | |
| LTM Jun 2026 | $122.3M | +533.7% | -4.3% | 6.6% | |
| LTM Sep 2026 | $97.28M | +1184.4% | -46.7% | 4.8% | |
| LTM Sep 2026 | $85.81M | +3.2% | +10.7% | 7.5% | |
| LTM Mar 2026 | $52.34M | +708.9% | — | 47.5% | |
| Peer median (excluding IOSP) | $97.28M | +3.2% | -5.6% | 6.0% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| Deferred Income Tax | 6.4M | (5.5M) | 3.6M | (39.3M) | (10.2M) |
| Stock-Based Compensation | 4.4M | 6.7M | 8M | 8.5M | 8.1M |
| Change in Working Capital | (48.1M) | (90.1M) | 20.6M | (18.9M) | (48.4M) |
| Accounts Receivables | (31.4M) | (55.5M) | (12.6M) | 4.3M | 21.6M |
| Inventory | (62M) | (98.5M) | 83M | (11.8M) | (6.6M) |
| Accounts Payables | 90.2M | 54.2M | (26.9M) | (4.5M) | (32.8M) |
| Other Working Capital | (44.9M) | 9.7M | (22.9M) | (6.9M) | (30.6M) |
| Other Non-Cash Items | (5.3M) | (2.5M) | (3.3M) | 155.1M | 28.6M |
| Operating Cash Flow | 93.2M | 81.7M | 207.3M | 184.5M | 138.3M |
| Capital Expenditures | (39.1M) | (42.3M) | (62.1M) | (41.4M) | (50.3M) |
| Acquisitions (Net) | 3M | 2M | (34.7M) | (200K) | (700K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | (1.8M) | 100K | 500K | (24.1M) |
| Investing Cash Flow | (36.2M) | (42.1M) | (111.8M) | (62M) | (75.1M) |
| Debt Repayment | (600K) | (100K) | (2.3M) | 0 | 0 |
| Common Stock Issued | 10.1M | 2.2M | 900K | 2.1M | 500K |
| Common Stock Repurchased | (800K) | (5.9M) | (1.1M) | (700K) | (23.9M) |
| Dividends Paid | (28.8M) | (31.7M) | (35.1M) | (38.8M) | (42.4M) |
| Other Financing Activities | 100K | 1.8M | (1.4M) | 2.1M | 1.9M |
| Financing Cash Flow | (20M) | (33.7M) | (39M) | (35.3M) | (63.9M) |
| Effect of Forex Changes | (500K) | (600K) | 100K | (1.7M) | 4M |
| Net Change in Cash | 36.5M | 5.3M | 56.6M | 85.5M | 3.3M |
| Free Cash Flow | 54.1M | 39.4M | 145.2M | 143.1M | 88M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.